Advertisement
Advertisement

NNVC

NNVC logo

NanoViricides Inc.

1.42
USD
Sponsored
+0.02
+1.43%
Aug 07, 15:40 UTC -4
Closed
exchange

After-Market

1.45

+0.03
+2.11%

NanoViricides Inc. Profile

About

NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development of drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides, Inc. is headquartered in West Haven, Connecticut.

Info & Links

CEO

Anil Diwan

Headquarters

1 Controls Drive
Shelton, CT 06484, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.nanoviricides.com

Auditor

EisnerAmper LLP

Share holders

143

Employees

7

NanoViricides Inc. Statistics

Valuation Measures

Market Capitalization2

36.97M

Enterprise Value

33.76M

Enterprise Value/EBITDA(ttm)

-4.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.30

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-92.68%

Return on Invested Capital(ttm)

-94.55%

Return on Assets(ttm)

-81.59%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.62M

Net Income Available to Common(ttm)

-8.09M

Diluted EPS(ttm)

-0.43

Share Statistics

Beta (5Y Monthly)

1.67

52-Week Change

-10.13%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

21.65M

Dividend Yield

0.00%

Float4

22.16M

% Held by Insiders

3.60%

% Held by Institutions

10.30%

Balance Sheet

Total Cash(mrq)

3.21M

Total Cash Per Share(mrq)

0.15

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.17%

Quick Ratio(mrq)

3.17%

Book Value Per Share(mrq)

0.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.26

Free Cash Flow(ytd)

-5.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement